T

Traws Pharma Inc
D

TRAW

1.18500
USD
-0.05
(-3.66%)
مغلق
حجم التداول
41,115
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
9,469,177
المقالات
المزيد

العنوان: Traws Pharma Inc

القطاع: Healthcare
الصناعة: Biotechnology
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.